{"slug":"tirzepatide-semaglutide","verification":{"valid":true,"entries":2,"head":"b4c68fec813c944a63ecb6be872fc1a96a8586b48c9d7cb1690192f1b8d39a63"},"energy":{"passes":2,"tokens_in":32992,"tokens_out":3305,"tokens_total":36297,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"b4c68fec813c944a63ecb6be872fc1a96a8586b48c9d7cb1690192f1b8d39a63"},"provenance":[{"ts":"2026-06-29T22:40:02.346Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Semaglutide\nSlug: tirzepatide-semaglutide\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"dual_compound\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"},{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"},{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_","response":"{\n  \"slug\": \"tirzepatide-semaglutide\",\n  \"title\": \"Tirzepatide versus Semaglutide: Evidence-Graded Comparison on Weight Loss Pathways\",\n  \"body\": \"## What's breaking down\\n\\nNo specific degenerative condition is tied to the slug. The comparison centers on metabolic load from excess body weight. Higher body mass increases compressive forces on the spine, discs, and joints. Each extra pound of body weight can add roughly several pounds of force during movement, accelerating wear on weight-bearing tissues. Repair capacity in these areas can lag when mechanical stress stays high. Both compounds are studied for effects on body weight via GLP-1 pathways (and GIP for tirzepatide). Weight reduction is discussed as one route to lower that ongoing load rather than direct repair signaling.\\n\\n## Why Tirzepatide might help you\\n\\n1. What keeps failing: Excess body weight maintains high mechanical stress on the spine and joints. This pattern can outpace natural repair in discs and cartilage.\\n2. What Tirzepatide is studied to do: It targets dual GLP-1 and GIP receptors. Human trials show it produces greater average weight loss than semaglutide alone.\\n3. Therefore for you: If elevated body weight contributes to your load on weight-sensitive tissues, tirzepatide is discussed because studies link it to larger reductions in body mass. That reduction can decrease compressive forces. The framing stays on load reduction, not symptom masking.\\n\\n## Why Semaglutide might help you\\n\\n1. What keeps failing: Weight-related overload on joints and discs combines with metabolic stress that may limit tissue repair rates.\\n2. What Semaglutide is studied to do: It activates GLP-1 receptors. Multiple human trials demonstrate clinically meaningful weight loss.\\n3. Therefore for you: If body weight is part of the mechanical stress layer, semaglutide is discussed because trial data associate it with body mass reduction. Lower mass can ease forces on the lumbar spine and other structures. Emphasis re","tokens_in":32992,"tokens_out":3305,"cost":0,"prev":"genesis","hash":"817bbc12dd778f418449aa0de838e59cb622eeed9c8a6bbe13b8a304bacb1eab"},{"ts":"2026-07-17T02:43:19.579Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-semaglutide","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"817bbc12dd778f418449aa0de838e59cb622eeed9c8a6bbe13b8a304bacb1eab","hash":"b4c68fec813c944a63ecb6be872fc1a96a8586b48c9d7cb1690192f1b8d39a63"}]}